Park Ha Biological Technology Co., Ltd.

10-Year Study

BYAH.US · Consumer Defensive · US · Common Stock

Executive Summary: Park Ha Biological Technology Co., Ltd. has compounded at -95.9% annually over the last 10 years, with a maximum drawdown of 99.9% and an annualized volatility of 1323.0%.

1Y CAGR
-94.2%
3Y CAGR
-95.9%
5Y CAGR
-95.9%
10Y CAGR
-95.9%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
99.9%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
0.16
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
0.40
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
238.1%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2026 · +-66.7%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · -97.5%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
0%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
2026-44.7-58.2-42.94.311.4117.2——————-66.7%
2025-4.6-12.7152.38.3-2.2149.8-97.9-30.7-4.4-21.5-28.5-40.7-97.5%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 1323.0%. The dominant macroeconomic risk driver is HYG.US, accounting for 66.5% of variance. Idiosyncratic stock-specific factors contribute 2.0%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2024-12-0110000
2025-01-019538.950715421304
2025-02-018330.683624801271
2025-03-0121017.48807631161
2025-04-0122766.295707472178
2025-05-0122273.449920508745
2025-06-0155627.98092209856
2025-07-011147.8536875714178
2025-08-01794.912559618442
2025-09-01759.9363948658274
2025-10-01596.1844197138315
2025-11-01426.07311982608184
2025-12-01252.782187893963
2026-01-01139.90461352519654
2026-02-0158.505564387917325
2026-03-0133.38632750397456
2026-04-0134.81717011128776
2026-05-0138.79173290937997
2026-06-0184.26073131955484
Annual Return Matrix
YearAnnual Return
2025-0.9747217812106037
2026-0.6666666586693976
Total Factor Risk
13.230076921959894
VTI.US Exposure
-0.033577776187223074
VEA.US Exposure
0.11259049644549138
VWO.US Exposure
-0.0258139824026651
QQQ.US Exposure
0.2014291510326089
VTV.US Exposure
-0.0038146986262621576
IJR.US Exposure
0.02624893780120798
QUAL.US Exposure
-0.02354865671930928
SHV.US Exposure
0.03061904010530553
TLT.US Exposure
0.034648300691015266
LQD.US Exposure
-0.04261507869540684
HYG.US Exposure
0.6645838069371902
GLD.US Exposure
-0.0015039675975561052
USO.US Exposure
0.0017485019929092223
VNQ.US Exposure
-0.023304342319781922
BTC-USD.CC Exposure
-0.0047645105481453395
CPER.US Exposure
0.0026030059893164623
VIX.INDX Exposure
-0.0072686995170114675
UUP.US Exposure
0.03974330562543912
TIP.US Exposure
0.03173475092932705
Idiosyncratic Exposure
0.020262415063550167
Value Score
50
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
1323.0%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Forward P/EForward P/E RatioA valuation metric that compares the current stock price to estimated future earnings per share.Click for full definition →No estimate availableN/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Squeeze RiskShort Squeeze RiskA situation where a sharp rise in the price of a stock forces short sellers to buy shares to cover their positions, further driving up the price.Click for full definition →Low
Market Cap$3.9M
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators: distance from 50/200-Day SMA, 52-Week High proximity, Golden Cross trend signal, RSI momentum gauge, Fibonacci retracement levels, and Beta (market sensitivity).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+126.2%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-72.8%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
99.9% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
1.00
Market sensitivity coefficient
Trend SignalGolden Cross & Death CrossTechnical chart patterns that occur when a short-term moving average crosses over a long-term moving average.Click for full definition →
✦ Death Cross
Bearish — 50 SMA below 200 SMA
RSI (14-Day)Relative Strength Index (RSI)A momentum oscillator that measures the speed and change of price movements to identify overbought or oversold conditions.Click for full definition →
80
OversoldNeutralOverbought
Overbought
Fibonacci LevelsFibonacci RetracementTechnical levels based on mathematical ratios that indicate potential support and resistance areas.Click for full definition →
38.2% retracement-99.8%
50.0% retracement-99.7%
61.8% retracement-99.7%
% distance of current price from each 52-week Fibonacci support level.

Compare this AssetiRun a head-to-head backtest and risk analysis against similar assets.

BYAH.USvsCELH.US

Compare Park Ha Biological Technology Co., Ltd. vs Celsius Holdings Inc

BYAH.USvsCOST.TO

Compare Park Ha Biological Technology Co., Ltd. vs Costco CDR (CAD Hedged)

BYAH.USvsCOCO.US

Compare Park Ha Biological Technology Co., Ltd. vs Vita Coco Company Inc

Frequently Asked Questions & Methodology

Is Park Ha Biological Technology Co., Ltd. a high-risk investment?

Park Ha Biological Technology Co., Ltd. (BYAH.US) has an annualized volatility of 1323.0% and experienced a maximum drawdown of 99.9% over the last 10 years. Its primary macro risk driver is HYG.US.

What is the 10-year return of BYAH.US?

Over the past 10 years, BYAH.US has generated a Compound Annual Growth Rate (CAGR) of -95.9%. It has had a positive return in 0% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Park Ha Biological Technology Co., Ltd.

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest